×

Network disruptions

We have been experiencing disruptions on our local network which has affected the stability of these web pages. We have been working with IT support team to get this fixed as a matter of urgency and apologise for any inconvenience.

PDB Information

PDB4C0C
MethodX-RAY DIFFRACTION
Host OrganismESCHERICHIA COLI K-12
Gene SourceTRYPANOSOMA CRUZI
Primary Citation
4-Aminopyridyl-Based Cyp51 Inhibitors as Anti-Trypanosoma Cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency.
Calvet, C.M., Vieira, D.F., Choi, J.Y., Kellar, D., Cameron, M.D., Siqueira-Neto, J.L., Gut, J., Johnston, J.B., Lin, L., Khan, S., Mckerrow, J.H., Roush, W.R., Podust, L.M.
J.Med.Chem.
HeaderOxidoreductase
Released2013-08-01
Resolution2.040
CATH Insert Date24 Aug, 2014

PDB Images (3)

PDB Prints

PDB Chains (1)

Chain ID Date inserted into CATH CATH Status
A 25 Aug, 2014 Chopped

CATH Domains (1)

Domain ID Date inserted into CATH Superfamily CATH Status
4c0cA00 27 Aug, 2014 1.10.630.10 Assigned

UniProtKB Entries (1)

Accession Gene ID Taxon Description
Q7Z1V1 CP51_TRYCC Trypanosoma cruzi strain CL Brener Sterol 14-alpha demethylase
CATH-Gene3D is a Global Biodata Core Resource Learn more...